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Purpose: This study aimed to compare lens capsule-related problems in mature versus non-
mature senile cataracts in patients undergoing phacoemulsification surgery.
Methods: A total of 295 patients with senile cataract were divided into two groups according to 
lens maturation: 105 patients with mature senile cataract comprised Group 1 (study group) and 
the remaining 190 with non-mature senile cataract comprised Group 2 (control group). Prior to 
surgery, ophthalmological examination was undertaken. Patients’ best-corrected visual acuity 
and intraocular pressure were measured and a slit-lamp examination and funduscopy performed. 
All examination data were recorded and any capsule-related problems during surgery were also 
recorded. Patient files were reviewed retrospectively and compared between groups. Fisher’s 
exact test was used in the statistical analysis.
Results: In Group 1, the capsule-related problems found were: inability to complete capsulor-
hexis (seven eyes [6.6%]), posterior capsular perforation (three eyes [2.8%]), and conversion 
to extracapsular surgery (one eye [0.9%]). A posterior capsular perforation was seen in one eye 
(1%) in the control group. An intraocular lens was inserted into the sulcus in six eyes (5.7%) 
and one anterior chamber (0.9%) in Group 1 and into the sulcus in one eye (0.5%) of Group 2. 
The lens was inserted into the capsular bag in all other patients.
Conclusion: Delaying surgery in patients with cataracts creates a high risk for capsule-related 
surgical complications. Although capsule dyes make capsulorhexis easier, capsulorhexis is the 
most problematic phase of phacoemulsification in mature cataracts.
Keywords: mature senile cataract, non-mature senile cataract, capsulorhexis
Introduction
Cataract is one of the most common causes of treatable blindness, especially in devel-
oping countries.1 The prevalence of cataract in the world varies according to age and 
geographic area.1 In recent years, cataract surgery has become safer and more effec-
tive due to surgical innovations;2 however, phacoemulsification (PE), the currently 
preferred surgical technique, is indicated more for early stage cataract than previous 
techniques.3 Although PE is safe and effective, there are difficulties in implementing this 
procedure in patients with advanced cataract, which is a serious problem in patients of 
poor socioeconomic status in developing countries who have delayed having surgery.4,5 
Changes can occur in the lens capsule and the lens contents of a mature cataract over 
time. These changes make it difficult to perform surgical procedures.5–7 One of the 
most significant problems is changes in the lens capsule.8
The lens capsule is a transparent basal membrane that contains structural elements 
of the lens and epithelial cells and fibers that surround and protect the lens.1 It differs 
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from other basal membranes in the body in that it continu-
ously thickens. The anterior capsule, measuring 8 µm thick 
at birth, may thicken with increasing age to 14 µm.1,9 Patients 
with advanced cataract frequently have capsular fibrosis, 
adhesions, calcification, and weakness of the zonules.3,9 In 
addition, advanced lens density prevents the red fundus reflex 
produced by the coaxial light of the microscope, making it 
difficult to differentiate the edge of the anterior capsule from 
the underlying white lens matter. In these cases, applying 
pressure on the lens capsule during capsulorhexis can cause 
irregular capsule rupture because of the increased and lique-
fied lens material. When the capsule is first pierced, milky 
liquefied cortical matter can leak into and thus obscure the 
view of the anterior chamber.10,11 Previous surgical techniques 
that did not require capsulorhexis to be completed generated 
fewer complications than PE. However, proper capsulorhexis 
is necessary for seamless PE surgery.9,11
In the study reported here, we aimed to compare surgical 
problems caused by the lens capsule in patients with mature 
versus non-mature senile cataracts.
Materials and methods
A total of 295 eyes of 295 patients who underwent cataract 
surgery in our clinic were included in this retrospective 
study. The study was approved by the ethics committee of 
our university and conducted according to the tenets of the 
Declaration of Helsinki. Informed consent was obtained from 
all of patients for the surgical procedure and data collection. 
Exclusion criteria were traumatic cataract, infection, glau-
coma, and uveitis.
Full ocular examination – including determination of 
best-corrected visual acuity, intraocular pressure measure-
ment, slit-lamp examination, funduscopy, ultrasound, and 
biometry – was undertaken prior to surgery. Patients were 
divided into two groups according to maturation of the lens. 
The first group (study group) had white mature cataract, 
determined according to the Lens Opacities Classification 
System III criteria. The second group (control group) had 
non-mature senile cataract.
All cataract surgeries were performed by one surgeon 
(LA). Cyclopentolate 1% and phenylephrine 10% eye drops 
were instilled to dilate the pupils before surgery. The eyes 
and surrounding adnexa were cleansed using 5% and 10% 
povidone-iodine solution, respectively. A clear corneal inci-
sion was made and continuous, curvilinear capsulorhexis was 
performed. Trypan blue was used as capsule dye to allow the 
anterior capsule to be seen in the mature cataract group but 
not in the control group. PE equipment (AMO WhiteStar 
Signature® Phaco System, Abbott Medical Optics, Santa Ana, 
CA, USA) was used in the surgery. The nucleus was acquired 
with quick chop and PE. Irrigation and aspiration were per-
formed for cortical material. An acrylic foldable intraocular 
lens (Ocuva A625, VSY Biotechnology, Istanbul, Turkey) was 
inserted into the capsular bag, under the side port irrigation. 
An intracameral antibiotic (1 mg/0.1 mL, Cefuroxime axetil) 
was applied into the anterior chamber at the end of the 
surgery. Topical corticosteroid eye drops (dexamethasone 
0.1%) and antibiotic eye drops (ciprofloxacin 0.3%) were 
used postoperatively by patients six times per day for the 
following 2 weeks.
Any capsulorhexis problems and surgical complications 
occurring during surgery were recorded. All the data obtained 
for the two groups were compared. Fisher’s exact test was 
used for the statistical analysis.
Results
Patient characteristics
In Group 1 (n = 105), 105 eyes of 59 female and 46 male 
patients with mature cataract stage 4 were operated on. The 
mean age of patients in this group was 69.93 ± SD 8.60 (range 
40–88) years old. In Group 2 (n = 190), 91 eyes of 96 females 
and 94 males with senile cataract were operated on. The mean 
age of patients in this group was 67.42 ± 8.4 (range 47–84) 
years old (Table 1). In Group 1, visual acuity was light percep-
tion to counting fingers. The mean intraocular pressure in this 
group was 14.22 ± 3.14 (range 10–26) mmHg. In Group 2, 
mean visual acuity was 0.34 ± 0.25 Snellen units (range 
0.05–0.50) and mean intraocular pressure was 14.06 ± 2.90 
(10–24) mmHg.
The capsule-related problems found during cataract 
surgery (PE) were: inability to complete capsulorhexis in 
seven eyes (6.6%) of seven patients (four female and three 
male, mean age 72.71 ± 5.20 years old), posterior capsular 
perforation in three eyes (2.8%), (two female and one male, 
mean age 77.33 ± 6.11 years) and conversion to extracapsular 
cataract extraction in one eye (0.9%) (female, 84 years old) 
in the mature cataract group (Group 1). Posterior cap-
sular perforation was encountered as a complication in 
Table 1 The distribution of the demographic structure of patients
First group Second group
Male, n (%) 46 (44) 94 (49)
Female, n (%) 59 (56) 96 (51)
Total, n (%) 105 (100) 190 (100)
Age, years 69.93 ± 8.6* 67.42 ± 8.4
Note: *±: SD.






one eye (0.5%) (female, 72 years old) in the control group. 
Of the patients in whom capsule problems were detected, one 
had a Morgagnian cataract, four had white mature cataract, 
and two had corticonuclear cataract.
An intraocular lens was inserted into the sulcus in six eyes 
(5.7%) and one anterior chamber (0.9%) in Group 1 and into 
the sulcus in one eye (0.5%) in Group 2. Lenses were inserted 
into the capsular bag in all other patients (Table 2).
Compared with the control group, surgical problems 
occurred more often in the mature cataract group, and the dif-
ference between the two groups in this regard was statistically 
significant (P , 0.05) for the capsulorhexis stage. In terms 
of posterior capsular perforation, the difference between the 
two groups was not statistically significant (P = 0.347). For 
intraocular lens placement in mature cataract, anterior cham-
ber and sulcus placement occurred at a high rate, and was 
statistically significant for sulcus placement (P , 0.05).
Discussion
The current cataract surgery technique of choice, which has 
developed over time, is PE. Unlike with previous methods, 
its widespread use and the increasing surgical experience 
of its practitioners have reduced the indication time for 
cataract surgery. Previously used surgical procedures were 
invasive and the healing process was long,12–15 so they were 
more suitable for advanced-stage cataract. However, even 
though these techniques did not require capsulorhexis to 
be completed, thus resulted in fewer problems, PE requires 
capsulorhexis to be completed, meaning there is more risk 
of surgical complication. Capsulorhexis failure has been 
shown to have a negative impact on surgical success in mature 
cataract because of lens capsule changes.14,15
Thickening and calcification of the lens capsule and high 
pressure applied by the lens material to the capsule make it 
difficult to undertake capsulorhexis. The capsule is friable 
and tends to escape to the periphery during capsulorhexis. 
In such cases, rhexis can progress to the posterior capsule 
easily. Sometimes, PE must be converted to extracapsular 
cataract extraction with extended corneal incision.15–21 In 
mature cataract cases, the anterior chamber can be created 
with a dense viscoelastic device to overcome the tension on 
the capsule. To do this, the anterior capsule is perforated with 
a sharp cystotome then capsulorhexis is performed. Further, 
in mature cataracts, sometimes fundus reflexes cannot be seen 
because the anterior capsule obscures them. To resolve this 
difficulty, capsule dyes have been developed.22–24 In our study, 
we used trypan blue as the capsule dye in the mature cataract 
surgeries performed. Trypan blue, allowing us to see the cap-
sule, made the process capsulorhexis easier. We were unable 
to complete capsulorhexis in seven mature cataract patients 
and, in one case, extracapsular surgery was performed. Three 
patients had rupture of the posterior capsule at the same time. 
The appropriate capsulorhexis was performed in all patients 
in the control group. The capsule dye was not needed in these 
patients as their anterior capsule was easily seen.
With mature cataracts, lens changes play an important 
role during capsulorhexis. The increased lens volume applies 
pressure on the anterior capsule, making capsulorhexis 
difficult.25–31 When the capsule is pierced, milky cortex 
material can spill over into the anterior chamber and hamper 
visibility of the anterior capsule. In addition, discharge of the 
milky cortex material diminishes on pressure to the lens cap-
sule, so capsulorhexis becomes more difficult. In such cases, 
pressure balance can be achieved by adding a viscoelastic 
substance to the capsular bag and anterior chamber before 
proceeding with capsulorhexis. In the control group, the pres-
sure exerted on the capsule was stable after viscoelastic was 
inserted into the anterior chamber, allowing capsulorhexis 
to be performed easily.
Conclusion
In mature cataract cases, changes to the lens and capsule make 
it difficult to perform capsulorhexis and increase the risk of 
surgical complications when the PE technique is used. To 
reduce complications and increase surgical success in future, 
the obstacles preventing patients from having cataract surgery 
early must be determined and resolved.
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Abstract: We report an unusual case of iris rubeosis and hyphema caused by chemical injury 
due to household detergent. A 74-year-old man with a 15-year history of diabetes mellitus 
was refilling a container with household detergent at home. He splashed the detergent in his 
eyes. Slit-lamp examination revealed extensive epithelial damage to the left eye, leading to a 
persistent corneal epithelial defect. We used a bandage soft contact lens with levofloxacin eye 
drops as concomitant therapy in order to promote healing. However, a strain of fluoroquinolone-
resistant Corynebacterium colonized the eye, so that the corneal ulcer eventually became severe. 
Use of the bandage soft contact lens was discontinued. His antimicrobial agent was changed 
to cefmenoxime, a drug to which fluoroquinolone-resistant Corynebacterium is sensitive, and 
topical instillation of autologous serum subsequently promoted improvement of the ulcer. On day 
38 after injury, iris rubeosis led to hyphema and ghost cell glaucoma. With improvement of his 
corneal epithelial defect, the iris rubeosis and hyphema regressed and his visual acuity improved 
to 20/25 on the left eye. To the best of our knowledge, this is the first report of a case resulting in 
severe complications due to chemical injury by a neutral detergent. Ophthalmologists should be 
aware that corneal epithelial damage may become prolonged in elderly patients with diabetes, and 
unexpectedly severe when wearing bandage soft contact lens, with infection of Corynebacterium 
resistant to fluoroquinolones, even if the chemical agent is a neutral detergent.
Keywords: chemical injury, household detergent, persistent corneal epithelial defect, iris 
rubeosis, fluoroquinolone-resistant Corynebacterium, bandage soft contact lens
Introduction
Splashing chemicals into the eyes may not only occur as an occupational accident but 
also while using detergents or other products at home. Most kitchen detergents are 
neutral (pH 6–8) and are mainly composed of a surfactant, a stabilizing agent, and a 
sequestering agent. Even if a chemical injury occurs, the resulting keratoconjunctival 
damage is milder in most cases involving a neutral detergent than when an alkaline or 
acidic agent is the cause. To the best of our knowledge, no severe cases of eye injury 
caused by a neutral detergent have been reported.
On the other hand, a bandage soft contact lens (SCL) is used for treating a persistent 
corneal epithelial defect to prevent exfoliation of corneal epithelial cells, to protect 
from mechanical damage, and to maintain the wettability of the ocular surface.1–6 
Bacterial contamination using bandage disposable SCL is also reported,7,8 and causes 
bacterial keratitis and infectious endophthalmitis in severe cases.9,10
We report a rare case of corneal injury due to a neutral detergent that resulted in 
a persistent corneal epithelial defect, exhibiting obvious symptoms of intracameral 
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inflammation with iris rubeosis and hyphema after wearing 
a bandage SCL.
Case report
The patient was a 74-year-old Japanese man who splashed 
household detergent in his eyes at home in July 2009. He 
presented with bilateral eye pain and difficulty in opening 
his eyelids. Because the patient had suffered from diabetes 
mellitus for 15 years, he had undergone regular examinations 
for cataract and diabetic retinopathy at our hospital. Before 
the present injury, there was no diabetic retinopathy and the 
corrected visual acuity was 20/16 on both sides. At the time 
of injury, glycosylated hemoglobin was 8.9% and his antidi-
abetic drug therapy was limited to glimepiride (Amaryl®, 
Sanofi KK, Paris, France) at 1 mg in the morning. He was not 
taking an anticoagulant. The substance that entered his eyes 
was a neutral (pH 6.8) detergent (Charmy Awa no Chikara 
[Power of Suds], Lion Corporation, Tokyo, Japan), the major 
ingredient of which was a surfactant.
The right eye showed diffuse superficial keratitis, prob-
ably because little detergent had splashed into this eye. 
Hyperemia of the conjunctiva was the main finding and the 
ocular condition was grade G1 according to the Kinoshita 
classification.11 On the other hand, there was extensive 
corneal epithelial damage, conjunctival edema, and marked 
conjunctival hyperemia of the left eye, which was classified 
as grade G2 according to Kinoshita (Figure 1).
The eyes were irrigated with 2 L of physiological saline 
solution for about 20 minutes. Treatment was then started with 
oral prednisolone, ofloxacin eye ointment, and betamethasone 
eye ointment. Six days later, the right eye showed almost com-
plete epithelialization and visual acuity had returned to 20/20. 
However, although the size of the corneal epithelial defect 
in the left eye was smaller compared with that seen at the 
initial visit, edema and Descemet’s fold were unchanged. At 
10 days after injury, reduction of the corneal epithelial defect 
area was noted in the left eye, but visual acuity was still only 
hand movement. Because the epithelial defect was still pres-
ent at 12 days after injury, the patient was given a therapeutic 
bandage SCL (Breath-O®, Toray Industries Inc, Tokyo, Japan), 
and treatment was started using an antimicrobial agent (0.5% 
levofloxacin eye drops, Santen Pharmaceutical Co, Ltd, Osaka, 
Japan), a corticosteroid (0.1% betamethasone eye drops, 
Shionogi & Co, Ltd, Osaka, Japan), and sodium hyaluronate 
eye drops (0.1% Hyalein, Santen Pharmaceutical Co, Ltd, 
Osaka, Japan), four times daily. After 7 days of wearing 
the bandage SCL, hyperemia was exacerbated and bacte-
rial corneal infiltrates were suspected (Figure 2). Therefore, 
use of the bandage SCL and topical steroid instillation was 
discontinued. A Corynebacterium species resistant to fluo-
roquinolones was detected by culture on rubbing the inferior 
palpebral conjunctival sac with a sterile cotton swab, so his 
antimicrobial agent was changed to cefmenoxime, a drug to 
which fluoroquinolone-resistant Corynebacterium is sensitive. 
About one month after injury (10 days after starting use of the 
bandage SCL), the epithelial defect was almost completely 
resolved, except in a central area with opacity. In addition, 
corneal epithelial swelling was observed and the endothelial 
cell density was calculated to be 2237/mm2. Because re-
epithelialization did not progress, 50% autologous serum 
was instilled topically into the eyes. At 38 days after injury, 
the corneal epithelial defect was healed completely. However, 
hyphema occurred suddenly, with near-circumferential rubeo-
sis of the iris (Figure 3). The intraocular pressure was around 
35 mmHg, and ghost cell glaucoma developed. Treatment 
was started with acetazolamide at a dose of 750 mg/day and 
a topical long-acting beta-blocker (carteolol hydrochloride, 
Otsuka Pharmaceutical Co, Ltd, Tokyo, Japan) once a day. 
About 2 weeks later, the hemorrhage improved and secretions 
were absorbed, along with a decrease in intraocular pressure 
and spontaneous regression of rubeosis. Visual acuity was 
20/100 in the left eye. After the eye was confirmed to be free 
from infection, a topical steroid (0.02% fluorometholone eye 
Figure 1 (A) Slit-lamp photograph showing marked conjunctival hyperemia and 
conjunctival edema in the left eye. (B) There is an extensive corneal epithelial defect 
covering almost the entire cornea in the left eye.
Figure 2 The corneal epithelial defect has become smaller, but it is complicated by 
infection (arrows) in the left eye.






drops, Santen Pharmaceutical Co, Ltd) was administered to 
clear the opacity in the center of the cornea. At 5 months after 
injury, his visual acuity improved to 20/20 on the right and 
20/25 on the left. Fundus examination of the left eye revealed 
no diabetic retinopathy, no neovascularization, and normal 
cupping of the optic disc.
Discussion
This is a case of hyphema and iris rubeosis following sec-
ondary infection of a persistent corneal epithelial defect by 
Corynebacterium. The condition followed chemical injury 
by a neutral detergent.
When considering the cause of the onset of iris rubeosis 
in the present case, it seems highly improbable that rubeo-
sis due to diabetic retinopathy or other ischemic disease 
would undergo spontaneous remission after such a short 
time as 2 weeks. We could exclude exacerbation of diabetic 
retinopathy, internal carotid stenosis, uveitis, retinal isch-
emia, ophthalmic arteriovenous anomalies, and neoplastic 
disease.
However, with respect to inflammatory rubeosis like that 
seen in the present patient, spontaneous regression would be 
expected to occur with improvement of inflammation. Due to 
progress with antimicrobial agents, there are no recent reports 
concerning bacterial corneal ulcers complicated by hyphema 
and rubeosis. However, there are several reports of microbial 
keratitis infected by Corynebacterium, especially following 
use of a bandage SCL8 and after photorefractive keratec-
tomy and laser in situ leratomileusis.12,13 Corynebacterium 
is a genus of Gram-positive, rod-shaped bacteria, which 
are widely distributed in nature, are mostly innocuous, and 
constitute one kind of the normal bacterial flora found on 
the ocular surface.14–16 The corneal epithelium is always in 
contact with the external environment and is likely to come 
into contact with foreign bodies and pathogens. If there is a 
corneal epithelial defect, the risk of microbial keratitis will 
be increased.
Continuous wearing of an SCL is a known risk factor for 
microbial keratitis.17,18 Corneal epithelial damage is present 
and barrier function is impaired especially in patients who 
are prescribed a bandage SCL. Because continuous wearing 
of an SCL results in hypoxia and decreased metabolism in 
the cornea, this worsens the infectious keratitis already pres-
ent. In addition, administration of a corticosteroid might have 
caused the infection to flare. In order to promote healing of 
the persistent corneal epithelial defect, a bandage SCL was 
used, with levofloxacin eye drops as concomitant therapy. 
However, some recent reports from Japan demonstrate a high 
rate of fluoroquinolone resistance in cases of Corynebacte-
rium.15,16 In our case, a strain of fluoroquinolone-resistant 
Corynebacterium colonized the eye, so that the corneal ulcer 
eventually became severe and intracameral inflammation also 
became more severe.
On the other hand, topical instillation of autologous serum 
subsequently promoted improvement of the ulcer in our case. 
Jeng et al19 have reported the benefit of topical instillation of 
autologous serum in patients with persistent corneal epithelial 
defect, because it has a lower risk of infection and is more 
useful than a bandage SCL. There is only a remote possibil-
ity that topical instillation of autologous serum will cause 
progression of rubeosis.
What is the mechanism by which rubeosis and hyphema 
developed in this patient? It would be reasonable to con-
sider that inflammatory cytokines produced in response 
to chemical injury were responsible for the changes in 
our patient. Animal studies of alkaline injury have shown 
a significant increase in interleukin-1α and interleukin-6 
 levels in the cornea20 and that bevacizumab (an anti-vascular 
endothelial growth factor agent) is effective for preventing 
corneal  neovascularization.21 It is assumed that, after the 
initial chemical injury in our patient, persistent corneal ulcer-
ation caused by bacterial infection led to severe inflammation 
and release of the above-mentioned inflammatory cytokines 
from the corneal stroma into the anterior chamber, thereby 
increasing the concentration of cytokines in the aqueous 
humor. Moreover, increased interleukin-1β and interleukin-6 
levels in the retina have been reported following alkaline 
injury.22 In the present case, there is also a possibility that 
inflammatory cytokines were released from the retina into the 
vitreous fluid and then transferred to the anterior chamber, 
thereby causing rubeosis.
Furthermore, irrigation of the eye at home by this patient 
after the accident was only done for about 5 minutes, which 
is insufficient. In the future, ophthalmologists as well as 
emergency physicians and detergent manufacturers must 
inform the public that at least 15 minutes of irrigation is 
recommended as initial treatment at the time of injury.
Figure 3 (A) Slit-lamp photograph showing iris rubeosis (arrows) at circumferential 
pupil margin. (B) There is an obvious hyphema (arrow) in the left eye.
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In conclusion, the message conveyed by this case is that 
even when chemical injury is due to a neutral detergent, 
corneal ulceration may be persistent in elderly patients with 
diabetes who become infected with fluoroquinolone-resistant 
Corynebacterium, and unexpectedly severe in those wearing 
a bandage SCL.
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Abstract
Background The high-density silicone oil (Den-
siron), a mixture of F6H8 with silicone oil, has been
used in the management of retinal detachment (RD)
complicated by the presence of proliferative vitreo-
retinopathy (PVR) with varying rate of anatomical
success and visual outcomes.
Methods We conducted a prospective interventional
case series of 22 eyes in 22 children less than 18 years
diagnosed with complicated retinal detachment com-
plicated by the presence of PVR in inferior quadrant.
Results The mean age of the patients was
8.45 ± 3.36 years. There were 14 male and 8 female
children. Five patients presented with total RD, 5 had
subtotal RD and remaining 10 with inferior retinal
detachment. There were 8 children with PVR C1, 13
with PVR C2, 3 with PVR C3. All patient’s had
macula off RD at presentation. The anatomical success
in the form of attached retina was achieved in 21
(95.45%) eyes. Standard three-port pars plana vitrec-
tomy without scleral buckling under general anesthe-
sia was surgical technique employed in all cases.
Conclusion Densiron can be an important tampon-
ade agent in pediatric retinal detachment complicated
by PVR with increased success rate of retinal re-
attachment.
Keywords High-density silicone oil  Densiron 
Retinal detachment
Introduction
The treatment of inferior retinal detachment (RD) with
proliferative vitreoretinopathy (PVR) in the lower
retinal periphery and especially in children represents
a challenge for vitreoretinal surgeons. The incidence
of pediatric retinal detachment in children is quiet low
as compared to adults and reported to be 3.2 to 6.6%
[1]. The multi-factorial etiology of RD in children has
an effect on its management. The most common cause
of RD in children is myopia, trauma, congenital retinal
anomalies, previous intraocular surgery. The major
problem, associated with prognosis and management
in pediatric RD, is its delayed presentation, late
diagnosis, and its association with factors like inferior
dialysis, giant retinal tear making out makes the
management further difficult. The most important
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intraoperative factor affecting the prognosis of vitre-
oretinal surgery is the presence of proliferative
vitreoretinopathy (PVR) [2, 3]. Additionally, the
childhood RD is more likely to recur due to the
presence of adherent posterior hyaloid and contraction
of vitreous near breaks. In order to overcome these
factors, heavy oil tamponade has gained popularity
among vitreoretinal surgeons over the recent years
specially in cases of complicated RD with PVR in
children [1–4]. To the best of our knowledge, there is
no published study on efficacy and safety of Densiron
as tamponade agent for complex RDs in Indian
pediatric population. In the present interventional
case series, we investigated the efficacy and safety of
Densiron as a primary endotamponade in the treatment
of these complex retinal detachments in children of
Indian origin.
Materials and methods
This prospective interventional case series involved
22 eyes of 22 children with newly diagnosed pediatric
RD. The study was approved by the institutional
ethical committee and confirmed to the ethical stan-
dards stated in the 1964 Declaration of Helsinki.
Informed consent was obtained from parents of all the
subjects prior to enrollment in study.
The inclusion criteria of the study were all the
patients presenting with retinal detachment compli-
cated by the presence of PVR in inferior quadrant. The
intervention was in the form of vitreoretinal surgery
with the use of Densiron—a high-density silicone oil
as tamponading agent. The exclusion criteria were
children treated with previous retinal surgeries. The
initial evaluation included complete ophthalmological
examination which included determination of the best
corrected visual acuity under cycloplegia, intraocular
pressure tonometry, detailed slit lamp, and fundus
examination. Preoperatively, the new characteristics
of silicone oil were explained to all patients. Informed
consent was obtained from parents of all the subjects.
The patients were evaluated on day 1, 7, 2 weeks,
6 weeks, and 3 months. The details of type of RD and
grades of PVR, lens status (phakic or pseudophakic or
aphakic) were also noted. The surgical procedure
consisted of a standard three-port pars plana vitrec-
tomy without scleral buckling procedures under
general anesthesia. Vitreous was removed up to
anterior vitreous base along with release of anterior
and posterior tractions. In eyes with significant retinal
shortening due to long-standing retinal detachment,
circumscribed relaxing retinectomies were performed
to allow reattachment with perfluorocarbon liquid
intraoperatively. Retinal breaks were treated by cry-
ocotherapy and/or endolaser photocoagulation. Per-
fluorocarbon was replaced by balanced salt solution
followed by a slow injection of Densiron. Densiron
was aspirated with a 17G cannula under direct
illumination at the time of removal. The primary end
point was the anatomical re-attachment of retina
following removal of Densiron oil, and the functional
end point was improvement in preoperative visual
acuity following oil removal. The statistical analysis
was done using SPSS 14.0, and results were analyzed
using standard statistical tests.
Results
The mean age of the patients was 8.45 ± 3.36 years.
There were 14 male and 8 female children. Of these 22
children’s, 5 had total and subtotal RD each and 10
presented with inferior retinal detachment. There were
8 children with PVR C1, 13 with PVR C2, 3 with PVR
C3, but all patients had macula off RD. Of these 22
patients presenting with RD, only 3 were aphakic. The
duration of RD was 1.5 ± 0.90 months (Fig. 1,
Table 1). The mean preoperative BCVA was
0.014 ± 0.019, and mean post-operative BCVA was
0.077 ± 0.063 with average post-operative IOP spike
21.3 ± 7.28 mm Hg. The mean post-operative dura-
tion for silicone oil removal was 3.95 ± 1.25 months.
Of the 26 eyes, 9 (40.91%) eyes did not undergo
Densiron removal at 6 months but subsequently
underwent oil removal over next 03 months. The
anatomical success in the form of attached retina was
there in 21 (95.45%) eyes. Five eyes had a post-
operative IOP spike of more than 30 mmHg and were
started on topical betoxolol 0.5%, and none of these
five patients required trabeculectomy or other glau-
coma surgery (Table 2). There was a significant
association between duration of attachment of retina




Treating a complex RD is a very interesting and
difficult challenge. However in severe PVR, especially
in patients with previous multiple vitreous surgery and
persistent RD of the inferior quadrants, the outcome
can be discouraging even with silicone oil. Silicone oil
limits, but does not exclude, the diffusion of prolif-
erative cells and inflammatory mediators through the
vitreous cavity. If the silicone does not completely fill
the eye, it may lead to an incomplete tamponade in the
inferior retina, exposed breaks and an accumulation of
fluid containing proliferative cells. Therefore, in
patients with complex inferior RD a tamponade with
heavier than water density could be useful [5].
In the present study, we used Densiron 68 as a
primary endotamponade agent in children presenting
with complex inferior retinal detachment instead of
standard procedures. The standard vitreoretinal surgi-
cal procedure with ordinary silicone oil tamponade in
these patients was unlikely to achieve good anatomical
success in these complex pediatric RDs. In our case
series retinal reattachment was successfully achieved
in 95.45% patients using Densiron 68 tamponade
which is comparable to reattachment rates in adult
retinal detachment surgeries.
The higher success rate with Densiron as compared
to conventional heavy silicone oil was achieved since
it significantly reduces the fibroblast cells and its
mediators responsible for onset of PVR in inferior
retina [6–8]. In few studies, it has been noted that
Densiron tends to shift the PVR milieu to superior
side; hence, they advocated prophylactic laser photo-
coagulation or cryocoagulation in their patients. In a
n=22
PVR C-1 (8) PVR C-2 (13) PVR C-3 (1)
Primary /Redetachment
(6/2)
        Primary /Redetachment
(8/5)

















Age 8.5 ± 3.4 yrs
Gender(M/F) (14/8)
Duration of RD 1.5 ± 0.90 months
Lens status (PHAKIC/APHAKIC) 18/3
BCVA (pre-op) 0.014 ± 0.019
PVR grade (1/2/3) 8/13/1
Location of retinal detachment Inferior
BCVA (post-op) 0.077 ± 0.063
IOP spike 21.4 ± 7.3 mmHg
SOR duration 4.0 ± 1.3 months































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































prospective study by Wolf et al. using Oxane HD,
nearly 45% of the patients still required an endotam-
ponade with conventional silicone oil to maintain
retinal reattachment after repeat surgery [9]. Published
literature points out that ocular hypertension is an
important post-operative complications with use of
Densiron but can be easily controlled with medica-
tions only as observed in our study group. Other
common complications are severe inflammation,
emulsification/dispersion, new retinal tears in the
superior retina, retinal vascular changes, cataract,
and hypotension [10, 11]. There was no incidence of
anterior or posterior segment inflammation in our
study as also reported by Sanders et al. [7].
Though in our study, the rate of successful
anatomical reattachment was 95.45%, which was
similar to reattachment observed by Tognetto et al.
[12] as 92.3% but higher as compared to Sanders et al.
[7], who reported the primary retinal attachment as
45.8%. The reason for low success rate in Sanders
et al. could be that they used Densiron in all failed
retinal detachment cases. The major reason for
successful anatomical reattachment in our study was
due to less incidence of emulsification of silicone oil in
contrary to other studies [13–16].
Therefore, Densiron can be an important tampon-
ade agent in pediatric retinal detachment complicated
by PVR with increased success rate of retinal re-
attachment. However, further studies with large num-
ber of subjects and control group are required to
validate the efficacy and safety of Densiron oil as
tamponade agent.
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Abstract
Objective To evaluate the expression of toll-like
receptor 2 (TLR2) and toll-like receptor 4 (TLR4) on
CD14 ? cells in vitreous and blood of post-cataract
surgery acute endophthalmitis.
Design This prospective case–control pilot study
enrolled 16 patients of post-cataract surgery endoph-
thalmitis. All the cases were subjected to 23 G pars
plana vitrectomy (PPV). Ten patients undergoing 23 G
PPV for non-infectious conditions were taken as
controls.
Methods 23 G PPV was performed, and three
undiluted vitreous samples were collected in hep-
arinized syringes from the cases and the controls.
Simultaneous venous blood sample was taken, and
flow cytometry was performed to detect the expression
of TLR2 and TLR4 in vitreous and blood samples. The
vitreous and blood samples were incubated with
fluorescein isothicyanate (FITC) conjugated anti-
TLR2 monoclonal antibody Alexafluor (AX) 647
and anti-TLR4 monoclonal antibody phycoerythrin.
Data acquisition was done on a pre-calibrated flow
cytometer. TLR analysis of the acquired flow
cytometry data was then performed. Mean channel
fluorescence intensity (MFI) derived from fluores-
cence histogram was used to study the level of cell
surface TLR expression. MFI was calculated as a ratio
and recorded as the MFI of the TLR2 or -4 antibody
divided by the MFI of the isotype-matched negative
control antibody. Core vitrectomy was done as per the
comfort of the surgeon, and intravitreal antibiotics
vancomycin (1 mg/0.1 ml) and ceftazidime (2.25 mg/
0.1 ml) were injected. The cytological examination
was done on vitreous and blood sample.
Statistical analysis The median TLR 2 and TLR4
values between cases and controls were compared by
Mann–Whitney U test. Spearman’s rank correlation
test was used to assess the correlation between TLR
expression and disease activity.
Results Vitreous cytology evaluation showed the
presence of neutrophils (81.25%, n = 13), monocytes
(68.75%, n = 11) and lymphocytes (62.50%, n = 10).
The level of expression of TLR2 in vitreous showed a
statistically significant correlation with an increase in
the time interval of cataract surgery and intervention
for endophthalmitis (p\ 0.05), but the same was not
observed for TLR4. A drift toward higher level of
expression of TLR2 and TLR4 in vitreous was
observed in patients with poor outcome.
Conclusion TLR2 levels increase with the delay in
presentation; thus, TLR2 ligands in vitreous could
serve as a good target for the treatment of
endophthalmitis.
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Introduction
Postoperative endophthalmitis is one of the most
dreaded complications after cataract surgery. In view
of the poor prognosis of these cases [1], there has been
an increasing interest to understand the basis of
pathogenesis of the disease to improve the outcome
by targeting the critical areas. It is well understood that
in endophthalmitis it is not only the infection but the
associated inflammation that leads to visual loss due to
structural damage in the eye due to inflammation.
Toll-like receptors (TLRs) play a pivotal role in the
innate immunity. TLR has been implicated in the
recognition of the microbial agent by pathogen-
associated molecular patterns (PAMP) which further
signals for the host defense responses against the
pathogen. This involves the cascade of events involv-
ing inflammatory cytokines. The role of toll-like
receptors in endophthalmitis is well defined in the
experimental mice models, and it has been proven
from the biopsy samples of the retinal tissues [2]. In
real-life scenario, in endophthalmitis eyes, fragile
retina makes the retinal biopsy technically challenging
and impractical. The present study was planned to
determine the in vivo level of expression of TLR 2 and
4 in the cells present in vitreous and the serum of the
post-cataract surgery endophthalmitis. The hypothesis
tested in the present study was that if TLR2 and 4 can
be assessed from the vitreous samples of endoph-
thalmitis patients, then accordingly these can be
targeted in the treatment of endophthalmitis.
Material and methods
Study design
This was a single-center prospective pilot case–
control study and was approved by the institutional
research board and ethical committee. The informed
consent was taken in all cases as per the principles of
International Declaration of Helsinki. The study
enrolled 16 eyes of 16 patients of endophthalmitis,
occurring within six weeks after surgery for senile
cataract, presenting to the Retina Clinic of a tertiary
eye care centre. For the purpose of this study, post-
cataract surgery endophthalmitis was defined as
inflammation of posterior segment as evidenced by
slit-lamp biomicroscopy, ophthalmoscopy and ultra-
sound, with or without hypopyon. All cases presented
after 24 h of surgery and had localized corneal edema,
unlike the one seen in TASS. All had vision B
logMAR 2.0 and were subjected to 23 G pars plana
vitrectomy (PPV) with broad-spectrum intravitreal
antibiotics as initial treatment. Ten patients undergo-
ing 23 G PPV for non-infectious conditions like retinal
detachment and macular hole, during the same dura-
tion, were taken as controls.
We excluded the eyes with baseline vision of no
perception of light, complicated cataract, corneal
oedema or keratitis precluding vitreous surgery,
patients who underwent any additional surgery in the
same eye during follow-up period, patients with retinal
detachment or choroidal detachment and patients with
immunocompromised diseases like diabetes mellitus,
a history of cancer, prolonged use of steroids or other
immunosuppressive drugs.
A detailed history was taken in all cases. The
history was obtained regarding the time gap between
the cataract surgery and the symptoms of endoph-
thalmitis, and also the time gap between the surgery
and the withdrawal of vitreous sample. The symptoms
of endophthalmitis included pain, redness and
decrease in vision. History of any systemic disease
like diabetes mellitus, cancer, tuberculosis and use of
corticosteroids was recorded. The detailed ophthal-
mological examination included thorough slit lamp
biomicroscopy and indirect ophthalmoscopy with ?
20 D lens. Visual Acuity assessment was done on the
Snellen visual acuity chart, and the observed values
were converted to logMAR scale for statistical anal-
ysis. If the participant could not identify the largest
letter on the chart at 6 m (m), the distance was reduced
to 1 m. If he/she could not still recognize the largest
optotype, Visual acuity (VA) was classified using the
semi-quantitative ordinal scale of counting fingers
(CF), hand motions (HM), and perception of light
(PL). HM and PL were noted at a distance of 30 cm.
The vision of hand motions was done moving the
hands in a vertical direction and horizontal direction.
Similar reply 8 out of 10 times was taken as reliable.
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LogMAR 2 to 2.6 was assigned to vision counting
fingers at various distances of 1 to 6 m and log MAR
2.7 for vision HM and logMAR 2.8 for vision PL [3].
The anterior chamber reaction and flare evaluated
according to Standard Uveitis Nomenclature (SUN)
classification. The media clarity was graded from I–V
using an indirect ophthalmoscope (IDO) as in EVS
study [4].
Ultrasound B scan was done to confirm the vitreous
involvement in all cases. All the eyes underwent 23 G
PPV within 24 h of presentation to our hospital. At the
start of the PPV, three undiluted vitreous samples of
0.5 ml each were collected under guarded aspiration in
1 cc heparinized syringes on the aspiration tubing of
the cutter with air infusion in the posterior segment.
The samples were taken to the microbiology, cytology
and haematology laboratories immediately in syringe
plugged with sterile rubber cork so as to ensure no
contamination of the samples. A venous blood sample
was also taken from the arm in sterile anticoagulant
ethylene diamine tetra acetic acid (EDTA)-coated
tubes and sent to the haematology laboratory for
evaluation of TLR2 and TLR4 [5].
Core vitrectomy was done as per the comfort of the
surgeon, and intravitreal antibiotics vancomycin (1
mg/0.1 ml) and ceftazidime (2.25 mg/0.1 ml) were
injected. Postoperatively, all patients received oral
tablet levofloxacin 500 mg for 5 days, topical eye
drops vancomycin 5%, topical ceftazidime 5% and
cycloplegics. Any other intraoperative and postoper-
ative complications, if noted, were managed according
to the standard protocol.
The cytological examination was done on vitreous
and blood sample. Two smears were prepared from the
vitreous sample. One smear was fixed in absolute
alcohol and was subjected to Hematoxylin and Eosin
staining. The other smear was air-dried and subjected
to May Grunwald Giemsa staining. Smears were
evaluated for the presence of neutrophils, monocytes
and lymphocytes. A similar procedure was done for
the blood sample.
Flow cytometry was performed on a freshly
isolated blood sample and vitreous sample to inves-
tigate for TLR2 and TLR4 expression on Cluster of
Differentiation positive (CD14 ?) monocytes. 100 ll
of the blood sample was incubated with anti-TLR2
monoclonal antibody conjugated with fluorescein
isothicyanate(FITC) fluorescent dye Alexafluor (AX)
647 and anti-TLR4 monoclonal antibody conjugated
with FITC dye PhycoErythrin (PE) for 30 min in dark.
(Fig. 1) Further, 2 ml of flow cytometry lysing solution
(FACS; BD Biosciences) was added and incubated for
10–12 min. The sample was spun at 1200 to 1300
rotations per minute for 3 to 5 min. The supernatant
was discarded. The test tube with the remaining pellet
was used for flow cytometry. Data acquisition was
done on a pre-calibrated flow cytometer. A similar
procedure was done for the vitreous sample also.
Isotype-matched antibody controls were used to detect
nonspecific staining (Fig. 2).
TLR analysis of the acquired flow cytometry data
was then performed. The cytometry results were
obtained in the form of fluorescence histogram.
Monocytes were identified with the help of their
characteristic forward and side-scatter flow cytometry
profiles and CD14 (a monocyte marker). The his-
togram showed two peaks, blue colored which is the
level of expression of TLR2 and TLR4 in vitreous/
blood depending upon the sample being analyzed
(M1) and green colored which is isotype-matched
antibody controls to detect nonspecific staining (M2).
Mean channel fluorescence intensity (MFI) is calcu-
lated by the ratio of these two peaks [5]. MFI indirectly
equals the level of receptor density on the cell surface.
MFI of 1 represents no significant expression and MFI
of more than 1 indicated higher expression of
receptors.
The vitreous sample sent for microbiological
evaluation, included smear examination with potas-
sium hydroxide for fungus, gram staining for bacteria
and culture for both bacteria and fungus. The smear
Fig. 1 Smear prepared from vitreous fluid showing neutrophils
(red arrow head) and monocytes (green arrow head)Hema-
toxylin & Eosin, 400X maginification
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and culture sensitivity reports were used to further
guide the treatment. Laboratory confirmed growth was
defined as at least semi-confluent growth on a solid
medium, any growth on two or more media, or growth
on one medium supported by positive gram stain [6].
Patients were followed-up as per the institute’s
protocol. At each visit to the hospital, the patient was
subjected to a detailed anterior and posterior segment
examination including visual acuity assessment. The
eyes were examined for the visual outcome at three
months, and the expression of TLR was correlated
with the final outcome. A successful functional
outcome was taken as pre-study defined criteria of
best-corrected visual acuity (BCVA) C 20/400 (log-
MAR value B 1.3) [7], and a successful anatomical
outcome was taken as preserved anatomy of the globe
and no sign of active inflammation at follow-up.
Statistical analysis
The presence or absence of endophthalmitis was
considered as the primary explanatory variable. TLR2
and TLR 4 status in vitreous and blood was considered
as primary and secondary outcome variables, respec-
tively. Age, gender, hypopyon, visual acuity at
3-month follow-up period were considered as other
explanatory variables. Descriptive analysis of all the
parameters was done using a median and interquartile
range for quantitative variables, frequency and per-
centage for categorical variables. As the data obtained
was skewed, the medians and distributions of MFI
value of TLR 2 and TLR4 values between cases and
controls were compared by Mann–Whitney U test and
independent-sample median test. A similar compar-
ison was done in TLR 2 and TLR 4 values between
both genders and between people with good and poor
visual outcome. The association between quantitative
explanatory variables like visual acuity, hypopyon and
TLR values was done by Spearman’s rank correlation
coefficient (r-value). An r value of r\ 0.31 was taken
as modest correlation, 0.32 to 0.55 was taken as
moderate correlation, and[ 0.55 was interpreted as
strong correlation. P-value\ 0.05 was considered
statistically significant. IBM SPSS version 21 was
used for statistical analysis (Fig. 3).
Results
The mean age of cases was 55.50 years (range
12.75–66.50 years) and in controls, it was 54.50 years
(range 35.50–60.00 years). Both groups were age and
sex-matched. The time interval between cataract
surgery and vitreous sample withdrawal for endoph-
thalmitis varied between 2.00 days to 2.00 months.
(Mean value = 8.94 days). All patients had poor visual
acuity and the details of the initial presentation are as
in Tables1 and 2.
Vitreous cytology evaluation showed the presence
of neutrophils (81.25%, n = 13), monocytes (68.75%,
n = 11) and lymphocytes (62.50%, n = 10). The
details of the MFI of TLR2 and TLR4 in vitreous
and blood of cases and controls are shown in Table 3.
In vitreous, MFI of TLR2 in CD14 ? cells was[ 1
in 93.75% cases (n = 15) and\ 1 in 6.66% (n = 1)
cases (range -0.88 to 5.04, median value -1.22). The
MFI of TLR4 in CD14 ? cells in vitreous was[ 1 in
all 100% (n = 16) patients (range -1.01 to 9.74,
median value -1.85).
In blood, MFI of TLR2 in CD 14 ? cells was more
than 1 in 100% (n = 16) cases (range-1.02 to 6.15,
median value -1.26). MFI of TLR4 in CD 14 ? cells
Fig. 2 Fluorescence histogram showing TLR2 (left) and TLR 4( right) expression in vitreous M1 represents level of expression in
vitreous(blue peak) and M2 represents level of expression in isotype-matched antibody control (green peak). M1/M2 = MFI
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in blood was[ 1 in 87.5% cases (n = 14) and\ 1 in
12.5% cases (n = 2) (0.65 to 17.14, median value-
1.58) (Table 2). The median value of MFI of TLR2 and
TLR 4 in CD 14 ? cells of blood in cases and controls
was comparable (Table 3, p[ 0.05).
The level of expression of both TLR2 and TLR4
was not statistically significantly associated with the
demographic profile of the patient. A weak correlation
was present between the vitreous TLR2 and TLR4
with visual acuity at presentation (r = 0.190 and
0.498, respectively) which was not statistically sig-
nificant (p-value = 0.498 and 0.804, respectively).
The correlation between MFI of vitreous TLR2 and
TLR 4 to other baseline variables was not statistically
significant (0.456). There was a significant correlation
between the time interval from cataract surgery to
intervention for endophthalmitis with the level of
expression of vitreous TLR2.(r = 0.577) (p-value =
0.024). The correlation between MFI of vitreous
TLR4 with the time interval from cataract surgery to
intervention for endophthalmitis was weak
(r = 0.086) which was not statistically significant (p-
value = 0.761). (Table 4).
The microbiological evaluation of vitreous showed
growth of organisms in 3 (18.75%) endophthalmitis
patients. The organisms were methicillin-sensitive
Staphylococcus aureus (n = 1) and Staphylococcus
epidermidis (n = 2). Successful final functional out-
come was seen in 50% (n = 8) of patients. The median
value of MFI TLR2 and TLR4 in vitreous of endoph-
thalmitis patients did not correlate with the visual
outcome.
Table 1 Baseline variables
in study and control group
Study group (%) Control group
Visual acuity
Light perception LP HMCF 2(12.5%) 0
CFCF 6(37.5%) 0
CFto20/200 8(50%) 0
[ 20/200 0 1(10%)
0 9(90%)
Anterior segment inflammation
Cells ? 4 16(100%) 0
Hypopyon 16(100%) 0
Media clarity




Any systemic ailment (DM, cancer, uveitis) 0 0
Fig. 3 Fluorescence
histogram showing TLR2
(left) and TLR 4( right)
expression in blood. M1
represents level of
expression in blood (blue
peak) and M2 represents
level of expression in
isotype matched antibody





Postoperative endophthalmitis leads to the develop-
ment of an inflammatory reaction by the host. This
inflammatory response generated by the host is a
double-edged sword. On the one hand, it is necessary
to remove the infection, on the other, it is responsible
for causing irreversible damage to the retina [8]. The
inflammatory reaction is directly related to the amount
of innate and adaptive immune responses generated.
The most important step in the initiation of this
immune response is the recognition of pathogen by
TLRs present on cells associated with innate immunity
like neutrophils and monocytes [9]. TLR recognize
microbes by highly conserved biochemical structures
called pathogen-associated molecular patterns
(PAMP). TLR provides considerable specificity for a
different class of pathogens. TLR 1,2,4,5 and 6 are
present on the surface of cell and are involved in
























1 52 F 7 days 2.7 No growth ? ? ? 1.11 2.16 no yes
2 62 F 15 days 2.7 No growth ? ? - 2.83 1.14 no yes
3 21 M 2 days 2.7 No growth ? ? ? 1.28 2.14 yes yes
4 55 F 4 days 2 No growth ? ? ? 1.18 2.61 yes yes
5 60 F 6 days 2.3 Staphylococcus
aureus
? ? - 2.32 5.57 yes yes
6 70 M 60 days 2.7 Staphylococcus
epidermidis
? ? ? 4.41 4.17 no yes
7 55 M 7 days 2 Staphylococcus
epidermidis
? ? ? 1.27 1.39 yes yes
8 48 F 7 days 2 No growth ? ? 1.25 4.7 no yes
9 45 M 7 days 2.7 No growth ? 1.03 3.65 no yes
10 68 M 5 days 2.8 No growth ? ? 1.06 1.47 yes yes
11 56 F 4 Days 2.8 No growth ? ? ? 2.4 1.12 no yes
12 50 F 4 days 2.7 No growth ? ? 1.6 5.04 no yes
13 70 M 4 days 2 No growth ? ? 1.04 1.56 yes yes
14 72 M 4 days 2.3 No growth ? ? - 5.04 9.74 yes yes
15 45 M 3 days 2.3 No growth ? - ? 0.88 1.39 yes yes
16 62 F 4 days 2 No growth ? - ? 1.07 1.01 no yes
Table 3 Comparison of TLR2 and TLR4 expression in blood between cases and controls was comparable
Parameter Cases (N = 16) Controls (N = 10) Mann–Whitney U test Independent sample median test
TLR2 MFI 1.26(1.02–6.15) 1.38(1.01 to 2.84) 0.856 1.00
TLR4 MFI 1.58(0.65 to 17.14) 2.54(0.94 to 7.98) 0.897 0.688
Table 4 Correlation between delay in presentation to vitreous
TLR expression
Parameter Correlation P value
TLR2 MFI 0.577 0.024
TLR4 MFI 0.086 0.7611




recognition of PAMPs derived from bacteria, fungi
and protozoa while TLR3, 7, 8 and 9 are intracellular
and are involved in the recognition of viruses. The
TLR-mediated signaling is a complex and less under-
stood area. The cytokines and other mediators released
in the blood stream after any localized inflammation
may lead to upregulation of systemic TLR expression
[10].
TLR2 has been linked with the recognition of gram-
positive bacteria and TLR4 is recognized as a receptor
for gram-negative bacteria [11].
The current treatment protocol for endophthalmitis
involves the intravitreal injection of broad-spectrum
antibiotics and pars plana vitrectomy (PPV). The only
available anti-inflammatory treatment option is corti-
costeroids. There are conflicting reports on the role of
corticosteroids in the management of fungal endoph-
thalmitis which is not so rare in tropical countries
[12, 13]. Main concerns are emerging resistance to
antibiotics and lack of definitive treatment for inflam-
mation-induced damage [14].
It is a well-known fact that few cells are present in
the normal vitreous gel, predominantly in the cortex.
These cells consist of hyalocytes, astrocytes and glial
cells. Coupland et al. studied vitreous cytology and
noted that abundant neutrophils in vitreous fluid
cytology suggest bacterial (suppurative) endoph-
thalmitis [15]. Thus, the cytological evaluation of
vitreous is a valuable modality in diagnosing intraoc-
ular disease in adjunct to microbiological evaluation
[16]. In the present study also, cytological evaluation
of vitreous in endophthalmitis cases showed the
presence of neutrophils (87%%, n = 14), monocytes
(75%, n = 12) and lymphocytes (68.8%, n = 11).
In our study, the level of expression of TLR2 and
TLR4 on CD14 ? cells was evaluated by calculating
MFI from fluorescence histogram. In vitreous TLR2
evaluation of endophthalmitis patients, MFI of more
than 1 was seen in 93.75% of cases and MFI of TLR4
was observed to be more than 1 in 100% cases
(n = 16). This result suggests that upregulation of
TLR2 and TLR4 can be detected from the vitreous
samples of endophthalmitis patients. To the best of our
knowledge, this is the first study on the detection of
TLRs from the human vitreous of endophthalmitis
patients. Since the level of detection of TLRs in
endophthalmitis cases is high, it may be possible that
the neutrophils and monocytes were attracted to the
site of infection. The negative culture results in the
majority of the cases do not rule out endophthalmitis
as there was a delay in inoculation of samples due to
logistic reasons. In various studies, the culture posi-
tivity results in endophthalmitis seem to vary between
30–63% [17, 18]. The possibility of other microor-
ganisms like fungi or slow growing micro-organisms
cannot be excluded. Pan bacterial and pan fungal PCR
could be complementary to cultures from the vitreous
biopsy in clinical endophthalmitis cases.
With the added knowledge, more weapons can be
added to our armor to control the damage caused by
the induced inflammatory response. Every effort needs
to be done to save the precious vision of the patients.
More studies with larger sample size are needed to
validate the above result.
Studies conducted by Kumar et al. in experimental
mice models of Staphylococcus aureus endophthalmi-
tis have shown that microglial cells (macrophages of
central nervous system) have surface expression of
TLR and with pre-endophthalmitis injection of TLR2
ligand, Pam3cys, and there was decreased inflamma-
tion and increased phagocytic response [2]. In exper-
imental Bacillus cereus, endophthalmitis that retinal
function was preserved to a greater degree in TLR2
and TLR4 deficient mice proving that TLRs are an
important component of intraocular inflammatory
response in endophthalmitis [16, 19]. The above
studies suggest that mechanism of TLR2-mediated
immune response in different organisms may be
different and level of expression varies with timing
of sampling. The role of TLRs and polymorphonuclear
neutrophil infiltrations has also been established in
fungal endophthalmitis [20].
To identify the systemic influence of endophthalmi-
tis, the blood level of TLRs in CD14 ? monocytes
was evaluated. In blood, MFI of TLR2 was more than
1 in 100% patients and MFI of TLR4 was more than 1
in 87.5% of patients suggesting upregulation of
receptors in blood. However, the blood levels of
TLR in cases and controls were comparable. Chang
et al. evaluated TLR2 and TLR4 polymorphism in
blood neutrophils and monocytes of 9 patients with
acute anterior uveitis (AAU) by flow cytometry [5].
They found significant reduction in the level of TLR2
expression in patients of AAU when compared with
healthy controls. The 5 of 9 patients with AAU were
having a systemic disease, and 7 patients were positive
for HLA-B27. So, the possibility of specific alteration
could be due to associated systemic disease.
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The level of expression of TLR2 in vitreous showed
a statistically significant correlation with an increase
in the time interval of cataract surgery and interven-
tion for endophthalmitis (p\ 0.05), but the same was
not observed for TLR4. The correlation of TLR with
the delay in presentation is suggestive of the increas-
ing inflammatory load and uncontrolled multiplication
of invading pathogen with late presentation. This
highlights the importance of early intervention in
endophthalmitis cases. Further studies are needed to
understand the basis of the differential response of
TLR2 and TLR4.
To compare if there is any selective perturbation in
the level of expression of TLRs, ten age and gender-
matched control patients were taken who were under-
going vitrectomy for causes other than an infection.
TLR status in vitreous of control patients was not
evaluated due to acellularity of the sample. In the
blood of control patients, MFI of TLR2 was more than
1 in all patients and MFI of LTR4 was more than 1 in
90% of patients. The elevation of TLR in peripheral
blood has been proposed in many non-infective
diseases like neurological diseases, glial damage,
diabetes mellitus and heart diseases, etc.[21, 22].The
understanding of the TLR upregulation in non-infec-
tive diseases is still in its infancy. We did not
specifically exclude systemic co-morbidities in our
control group, and this could explain the presence of
TLR in the control group.
The varying level of TLR expression in vitreous
may depend upon the precise timing of vitreous
sampling, and there may be a dynamic change in the
level of TLR expression with the evolution of the
disease. The findings of the present study implicate
TLR activation in the pathogenesis of endophthalmi-
tis. Further studies involving a greater number of
patients are needed to confirm and expand the present
findings.
Study limitations
1 The study was conducted on small sample size.
2 The poor culture positivity in our study can be due
to non-availability of immediate inoculation of
vitreous sample for microbiological evaluation.
3 The timing of vitreous sampling after acquiring
the infection was variable. In the control group,
the patients with any systemic disease were not
excluded which can influence the level of expres-
sion of TLRs in blood.
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Abstract: Purpose:  This study aimed to evaluate the ocular alterations especially on retinal
microvasculature of obese patients and to determine the association of these
alterations with clinical features.
Material and Methods:  Height, body weight, blood lipid and glucose levels were
recorded in all patients. BMI was calculated.In all participants, biochemical
examinations were performed including cholesterol levels, fasting blood glucose,
fasting insulin,CRP,Hb A1C levels.The atherogenic index of plasma was calculated as
a logarithm of the ratio of the molar concentration (mmol/l) of TG to HDL-C (log
[TG/HDL-C]).Patients with a BMI ≤ 25 kg/m  2  were included in the control group.
Obese patients were sub-grouped into 3 according to their BMI as group 1 (BMI
between 30-34.99 kg/m  2  ), group 2 (BMI between 35-39.99 kg/m  2  ), and group 3
(BMI ≥ 40 kg/m  2  ).The macular and peripapillary thicknesses were measured using
an SD-OCT device. The foveal avascular zone (FAZ), the vessel density (VD) of the
superficial capillary plexus and deep capillary plexus of the macula, and the VD of the
retinal peripapillary capillary plexus (RPCP) for the optic disc were quantified by OCT-
A.
Results:  Totally 110 patients, 27 control cases,and 83 obese patients were included in
the study. There was not any significant difference between four groups regarding the
gender (p= 0.192). HbA1C, fasting insulin,HOMA-IR,CRP,AI levels were significantly
higher in obese patients compared with the control cases. Superficial (p= 0.003) and
deep (p= 0.001) VD’s of retina significantly decreased and FAZ significantly increased
(p= 0.032) in obese patients.  In correlation analysis performed between the clinical
features and OCT-A findings, the superficial and deep vessel densities inversely
correlated with age, BMI, Hb A1C, and AI.
Conclusion:  Retinal superficial and deep vessel densities are decreased in obese
patients and there was an inverse relationship between the retinal vessel densities and
age, BMI, Hb A1C, and AI.
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Purpose: This study aimed to evaluate the ocular alterations especially on retinal 
microvasculature of obese patients and to determine the association of these alterations with 
clinical features.  
Material and Methods:Height, body weight, blood lipid and glucose levels were recorded in all 
patients. BMI was calculated.In all participants, biochemical examinations were performed 
including cholesterol levels, fasting blood glucose, fasting insulin,CRP,Hb A1C levels.The 
atherogenic index of plasma was calculated as a logarithm of the ratio of the molar concentration 
(mmol/l) of TG to HDL-C (log [TG/HDL-C]).Patients with a BMI ≤ 25 kg/m2 were included in 
the control group. Obese patients were sub-grouped into 3 according to their BMI as group 1 
(BMI between 30-34.99 kg/m2), group 2 (BMI between 35-39.99 kg/m2), and group 3 (BMI ≥ 40 
kg/m2).The macular and peripapillary thicknesses were measured using an SD-OCT device. The 
foveal avascular zone (FAZ), the vessel density (VD) of the superficial capillary plexus and deep 
capillary plexus of the macula, and the VD of the retinal peripapillary capillary plexus (RPCP) 
for the optic disc were quantified by OCT-A.  
Results: Totally 110 patients, 27 control cases,and 83 obese patients were included in the study. 
There was not any significant difference between four groups regarding the gender (p= 0.192). 
HbA1C, fasting insulin,HOMA-IR,CRP,AI levels were significantly higher in obese patients 
compared with the control cases. Superficial (p= 0.003) and deep (p= 0.001) VD’s of retina 
significantly decreased and FAZ significantly increased (p= 0.032) in obese patients.  In 
correlation analysis performed between the clinical features and OCT-A findings, the superficial 
and deep vessel densities inversely correlated with age, BMI, Hb A1C, and AI.  
Conclusion: Retinal superficial and deep vessel densities are decreased in obese patients and 
there was an inverse relationship between the retinal vessel densities and age, BMI, Hb A1C, and 
AI.   




Obesity is an important public health concern worldwide, which is associated with 
increased risk for cardiovascular morbidity and mortality (1). Obesity, diabetes, dyslipidemia, 
insulin resistance, smoking and, hypertension are well-known risk factors that affect the vascular 
endothelium and endothelial response to the oxidative stress; resulting in microvascular 
remodeling (2-4). Nowadays, the atherogenic index of plasma is regarded as a novel predictive 
biomarker for cardiovascular diseases (5).  
 
Microvascular dysfunction is considered a crucial pathway in the development and 
progression of cardio-metabolic diseases. Inflammatory processes, oxidative stress, and 
endothelial dysfunction are the main mechanisms of microvascular dysfunction (6). Metabolic 
diseases are also known to have severe effects on the structure of the retinal circulation, mostly 
associated with endothelial dysfunction and inflammation (7). However, the data regarding the 
effects of obesity on ocular functions and retinal microvasculature is limited. Nowadays, retinal 
microvasculature is an easy-to-reach network structure where we can get the easiest and fastest 
information about the microvascular network all over the body by non-invasive methods (8). 
Retinal vessel diameters were shown to have a predictive role for long-term adult cardiovascular 
outcomes and atherosclerotic cardiovascular diseases (9). In daily ophthalmology practice, 
optical coherence tomography (OCT) is a widely used, non-invasive imaging method that offers 
high-resolution cross sectional scanning of ocular tissues. Moreover, with the development of 
spectral domain OCT (SD-OCT), the sensitivity and speed of OCT  systems are increased, 
enabling to visualize blood vessels through repeated scans. OCT angiography (OCT-A), provides 
detailed data on the microvascular structure of the retina and the choroid. 
  
 
This study aimed to evaluate the ocular alterations especially on retinal microvasculature 
of obese patients and to determine the association of these alterations with atherogenic index and 
body mass index.  
 
 
MATERIAL and METHOD 
This  retrospective study was performed in the ophthalmology department of Erzincan 
Binali Yıldırım University, Faculty of Medicine, Mengucek Gazi Training and Research Hospital  
between September 2019 and March 2020. The study was approved by the local ethics committee 
and performed in concordance with the principles of the 2008 Declaration of Helsinki. Informed 
consent was obtained from the participants.  
Study population 
Patients between the ages of 18 and 60 years, who were followed in our obesity center and 
agreed to participate in the study were included. The other inclusion criteria were as follows: 
refractive error ≤ ± 1 D or axial length between 22 and 24 mm, visual acuity ≥ 20/20, intraocular 
pressure ≤ 21 mmHg. Patients younger than 18 and older than 60 years of age, patients under 
treatment for diabetes mellitus, hyperlipidemia, or hypertension or any suspicious findings related 
to these diseases, patients diagnosed with any other systemic diseases such as sleep apnea 
syndrome, psychiatric disorders, cardiovascular diseases, kidney or renal failure, acute or chronic 
infection, anemia, thyroid pathologies that could affect the measurements were excluded from the 
study. Participants with a history of alcohol or drug use and smoking participants were excluded 
from the study. Extensive biochemical evaluation was  performed by taking fasting venous blood 
samples of all participants. Patients with any pathology in their values were excluded from the 
study. Patients having any ocular diseases (such as ectatic corneal diseases, chorioretinal 
diseases, cataract, glaucoma etc.) or ocular surgery were also excluded from the study. All 
patients were evaluated in endocrinology outpatient clinics, and patients with diabetes mellitus 
were not included in the study.  
 
Height, body weight, and blood lipid and glucose levels were recorded in all patients. 
Body mass index (BMI) was calculated using the following formula: BMI = body weight 
(kg)/height2 (m2).  
 
In all participants, for biochemical examinations, after 8h of fasting, 5 mL of venous 
blood was obtained from the cubital vein the following morning. Levels of total cholesterol (TC), 
low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), 
triglyceride (TG), fasting blood glucose (FBG), fasting insulin, and hemoglobin A1c (HbA1c) 
levels were determined. The Homeostasis Model Assessment of IR (HOMA-IR) was calculated 
for the assessment of insulin resistance (11). For the evaluation of subclinical inflammation, C-
reactive protein level was studied. The atherogenic index of plasma (AI) was calculated as a 
logarithm of the ratio of the molar concentration (mmol/l) of TG to HDL-C (log [TG/HDL-C]) 
(12).  
 
Patients with a BMI ≤ 25 kg/m2 were included in the control group. All obese participants 
had a history of at least 5 years of obesity. Obese patients were sub-grouped into 3 according to 
their BMI as group 1 (BMI between 30-34.99 kg/m2),  group 2 (BMI between 35-39.99 kg/m2), 
and group 3 (BMI ≥ 40 kg/m2). Overweight patients having a BMI between 25.01 and 29.99 were 
not included in the study.  
 
Detailed ocular examinations were performed in all patients. All participants underwent 
detailed ophthalmologic examinations.  In this context, refraction measurement (Tonoref III, 
Nidec Co. Ltd, Aichi, Japan), best corrected visual acuity, slit lamp biomicroscopy, indirect 
ophthalmoscopy, non-contact biometry (AL-SCAN, Nidek Co. Ltd, Aichi, Japan), intraocular 
pressure (IOP) (Tonoref III, Nidec Co. Ltd, Aichi, Japan) measurement were carried out.   Retinal 
nerve fiber layer thickness (RNFLT), central macular thickness (CMT), and ganglion cell layer 
thickness (GCLT) were measured by SD-OCT , FAZ and VD measurements examined by OCT-
A (RS-3000 Advance AngioScan (Nidek Co. Ltd, Gamagori, Japan) ). Only the right eyes of the 
participants were examined.  
Scan Protocol 
The macular and peripapillary thicknesses were measured using an SD-OCT device 
(Nidek Co. Ltd., Aichi, Japan). The foveal avascular zone (FAZ), the vessel density (VD) of the 
superficial capillary plexus (SCP) and deep capillary plexus (DCP) of the macula, and the VD of 
the retinal peripapillary capillary plexus (RPCP) for the optic disc were quantified by OCT-A 
(RS-3000 Advance, Nidek Co. Ltd., Gamagori, Japan). The Nidek RS-3000 Advance OCT 
system and updated AngioScan software were used to evaluate SD-OCT and OCT-A images. The 
fovea is focused on using an OCT-A prototype internal fixation lamp, and 3x3 mm macula cubes, 
each consisting of 256 B-scans are generated. For RPCP, the scans included a 2.4 × 4 mm disc 
map centered on the optic nerve head. The macular and peripapillary vascular density as well as 
FAZ can be automatically calculated with this device.  
The SD-OCT and OCT-A measurements were performed by an experienced 
ophthalmologist after pupil dilation with 1% tropicamid eye drop (Tropamid, Bilim Ilac Ltd, 
Istanbul, Turkey). In cases where the signal strength index quality was <7/10, scanning was 
repeated. The FAZ and VD measurements in the superficial capillary plexus (Figure 1) and deep 
capillary plexus were measured. The automated segmentation determines the en face slab for the 
superficial retinal layer and deep retinal layer to extend from the internal limiting membrane to 
13 μm below of the inner nuclear layer,  and 8 μm below of the inner nuclear layer to 13 μm 
below of the outer nuclear layer respectively. VD was calculated as the percentage area occupied 
by flowing blood vessels in the selecting region. The VD of the retinal peripapillary capillary 
plexus (RPCP) for the S/I and TSNIT sectors can be observed from the OCT-A scans of the 
peripapillary area (Figure 2).The average retinal nerve fiber layer thickness (RNFLT) and central 
macular thickness (CMT) were also measured through SD-OCT analysis.  
Statistical Analyses 
Statistical analyses were performed with the SPSS version 21.0 (SPSS Inc, Chicago 
Illinois) statistical program. The parametric variables were expressed with mean ± standard 
deviation, while categorical variables were expressed with percentage (%). In the comparison of 
parametric data between 2 independent groups, an independent sample t-test was performed. For 
non-normally distributed data, the analysis was performed with the Mann-Whitney U test.  In 
more than two group comparisons; One-Way Anova and Bonferroni post-hoc analysis were used 
for parametric data. Pearson correlation analysis was performed to determine the association of 




Totally 110 patients, 27 control cases (24 female, 3 male), and 83 obese patients (62 
female, 21 male), were included in the study. There was not any significant difference between 
the control cases and obese patients regarding gender (p= 0.180).  
 
The participants were grouped into four according to their BMI as follows;  
 Control group: BMI between 20-25 kg/m2: 27 patients (24 female, 3 male) 
Group 1: BMI between 30-35 kg/m2: 27 patients (21 female, 6 male) 
Group 2- BMI between 35.01-40 kg/m2: 27 patients (22 female, 5 male) 
Group 3- BMI > 40 kg/m2: 29 patients (19 female, 10 male) 




Demographic features and laboratory data of the study participants are summarized in 
Table 1. Hemoglobin A1C, fasting insulin, HOMA-IR, CRP, TG, HDL-C, and AI levels were 
significantly different between groups (p=0.008, p=0.001, p=0.001, p=0.001, p=0.015, p=0.001, 
p=0.008, respectively).  
 
 
Ocular findings of study participants are summarized in Table 2. There was not any 
significant difference between groups regarding the RNFLT, GCLT, CMT, or RPCP values. 
However, superficial and deep global vessel densities were significantly decreased in obese 
patients (p=0.003, p=0.001, respectively). FAZ measurements were significantly higher in obese 
patients (p=0.032). 
In correlation analysis performed between the clinical features and OCT-A findings, there 
VD superficial and deep vessel densities inversely correlated with age, BMI, HbA1c, and AI; 




In this study, we investigated the ocular findings in obese patients and we did not 
determine any significant alteration in retinal nerve fiber layer thickness, ganglion cell layer 
thickness, central macular thickness, or radial peripapillary capillary plexus vessel density with 
obesity or with an increase in BMI. However, both superficial and deep vessel densities of retina 
decreased with obesity. To the best of our knowledge, this is the first study evaluating the 
relationship of retinal vascular alterations with metabolic parameters in obese patients and we 
determined that with an increase in age, BMI, Hb A1C and/or, atherogenic index, superficial and 
deep vessel densities of the retina was decreasing significantly.  
In recent years, the OCTA device has been widely used due to its short imaging time and 
no side effects. Nidek has recently updated the AngioScan software, but the normative data for 
the new version of the device are limited in the literature (10). Although it is not possible to 
standardize the measured values since different gravity techniques are used in different OCTA 
devices, the benefit of the evaluated data in the ophthalmology clinics is obvious in terms of 
evaluating the retinal microvascular structure. 
Obesity is a well-known risk factor for microvascular alterations and remodeling. In this 
study, we investigated the ocular changes in retinal microvasculature in obese patients and 
associations of these alterations with metabolic parameters. We determined an inverse correlation 
between BMI and superficial and deep retinal vessel densities. Similar to our results, in a meta-
analysis, Köchli et al reported that a higher BMI was associated with narrower retinal arteriolar 
and wider venular diameters in children (13). In another meta-analysis Boilot et al (14) also 
reported that higher BMI was associated with narrower retinal arteriolar and wider venular 
calibers. We also determined a significant decrease in both superficial and deep vessel densities 
of the retina with an increase in BMI.  
With an increase in BMI, there was a significant increase in AI, and a significant decrease 
in superficial and deep vessel densities of the retina. Moreover, there was an inverse significant 
correlation between AI and vessel densities. To the best of our knowledge, this is the first study 
in the literature evaluating the association of AI with OCT-A findings. On the same way with our 
findings, Krasnicki et al (15) reported that flow disturbances within the ocular blood vessels of 
patients with type 2 diabetes were associated with atherogenic changes of coronary arteries. In a 
population-based cohort study, Shankar et al (16) reported that wider retinal venules were 
positively associated with the risk of developing obesity, suggesting a role for microvascular 
dysfunction in early periods of obesity. However, in a recent population-based cohort study, it 
was reported that; age and FPG were inversely associated with retinal microvascular functions, 
but 24-h systolic blood pressure, waist circumference, and total-to-HDL cholesterol ratio were 
not associated with these microvascular functions (17). Xiao et al (18) also reported that 
adolescents with dyslipidemia had significantly narrower retinal arteriolar diameters compared 
with normolipidemic counterparts, but they did not determine any significant relationship 
between lipid subclass levels and central retinal venular equivalent. We also determined an 
inverse relationship between age and the retinal vasculature. Nowadays, the atherogenic index of 
plasma is regarded as a novel predictive biomarker for cardiovascular diseases and we believe 
that it may also be playing an important role in vascular alterations of the retina (5, 19).  
Hb A1C has been defined to have a prognostic value for cardiovascular diseases in non-
diabetic patients (20, 21). In this study on non-diabetic patients, we also determined that there 
was a significant increase in Hb A1C levels with an increase in BMI in obese patients and there 
was an inverse correlation between HbA1c and superficial and deep vessel densities of the retina.  
In this study, we did not determine any association between serum CRP levels and OCT-
A findings. In previous literature, the data regarding the association of CRP levels with 
cardiovascular risk assessment is conflicting (22, 23). Though CRP is a sign of inflammation, it 
may be affected by many other factors and in this study, though in obese patients, the mean CRP 
levels were significantly higher than that of the control cases, the CRP levels were still low. The 
low differences in mean CRP levels between groups may be associated with the exclusion of all 
patients with any chronic diseases from the study. This low difference may be the reason, we did 
not determine any association between the CRP levels and OCT-A findings.   
There are some limitations of this study that should be mentioned. First is that, though we 
excluded all patients with any systemic diseases including primary hypertension, we did not note 
systolic and diastolic blood pressure values, which are parameters that could affect OCTA 
measurements. Secondly, while there was not any significant difference between groups 
regarding gender, evaluating males and females in different groups may be more appropriate, 
since metabolic factors may have different effects on both genders. The other limitation is 
overweight patients having a BMI between 25.01 and 29.99 were not included in the study 
because there was no follow-up patient with these BMI values in the obesity center.  
In conclusion, retinal superficial and deep vessel densities are decreased in obese patients 
and there was an inverse relationship between the retinal vessel densities and age, BMI, Hb A1C, 
and AI. Recently retinal vessel alterations are shown to be sensitive microvascular biomarkers for 
cardiovascular risk stratification. Due to the association of these retinal vasculature alterations, 
which can be investigated with non-invasive methods, we suggest that retinal vasculature should 
be evaluated in patients with metabolic risk factors, such as elevated AI, BMI and older age, to 
treat these vascular alterations as early as possible and predict the cardiovascular morbidity and 
mortality at early stages. It is obvious that the cross-sectional data can provide limited 
information in this study where the atherogenic index and BMI effects were investigated on the 
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Legends: 
Table 1. Demographic features and laboratory data of the study participants. 
Table 2. Ocular findings of the study participants. 
Table 3. Correlation analysis performed between the clinical features and OCT-A findings. 
Figure 1. OCTA image of a 29-year-old woman with BMI = 32 kg / m2 . The FAZ metrics were 
autodetected by the AngioScan software. The image also displays VD measurements in the SCP 
layer. 
Figure 2. Peripapillary vessel density colored map and VD distribution at the level of the RPCP 
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Table 1. Demographic features and laboratory data of the study participants. 
 




Group 1  
(BMI between 30-
35 kg/m2) (n:27) 




(BMI > 40 
kg/m2) (n:29) 
P-value 
Age (years) 42.03±10.44 43.12±10.87 39.55±9.97 39.41±10.32 0.122 
FBG (mg/dL) 89.18±15.28 89.22±11.87 93.77±10.22 95.86±7.10 0.112 
HbA1c (%) 5.28±0.25 5.40±0.30 5.51±0.24b 5.54±0.27c 0.008 
Fasting insulin 
(µIU/mL) 
6.48±5.26 12.26±6.17a 12.55±6.82b 14.76±10.61c 0.001 
HOMA-IR 1.41±1.12 2.75±1.53a 2.76±1.59b 3.63±2.93c 0.001 




178.15±36.79 193.80±46.97 186.34±39.69 179.23±41.60 0.115 
TG (mg/dL) 104.18±55.69 125.31±40.28a 129.65±48.52b 134.09±53.5c 0.015 
HDL-C 
(mg/dL) 
51.20±5.61 43.35±11.17a 43.15±9.59b 42.78±8.72c 0.001 
LDL-C 
(mg/dL) 
106.11±29.40 118.74±44.26 119.25±33.15 119.46±37.00 0.082 
AI -0.08±0.015 0.022± 0.025a 0.066±0.019b 0.071±0.025c 0.008 
FBG: Fasting blood glucose, HbA1c: hemoglobin A1C, CRP: C-reactive protein, HDL-C: high-density 
lipoprotein-cholesterol, LDL-C: low-density lipoprotein-cholesterol, AI: atherogenic index, a: statistically 
significantly different when group 1 is compared with the control group; b: statistically significantly different when 
group 2 is compared with the control group; c: statistically significantly different when group 3 is compared with 
the control group. The significant P values expressed with bold style. 
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Table 2. Ocular findings of the study participants 












Group 3 (BMI 





115.29±5.09 111.25±9.76 108.22±14.24 110.03±9.23 0.73 
GCLT, sup (μm) 101.03±3.76 100.11±7.60 97.85±8.78 99.27±7.70 0.532 
GCLT, inf (μm) 103.96±5.77 101.55±7.31 100.66±9.06 103.55±8.52 0.307 
CMT (μm) 260.40±14.00 260.63±20.50 259.18±24.56 265.10±21.26 0.698 
RPCP VD (%) 54.01±3.23 54.37±4.02 53.44±3.82 53.51±2.97 0.834 
FAZ (mm2) 0.32±0.083 0.40±0.13a 0.41±0.15b 0.41±0.21c 0.032 
SCP VD (%) 43.77±1.80 40.48±4.40 39.37±5.50b 37.62±5.88c 0.003 
DCP VD  (%) 38.03±3.56 32.33±7.98a 32.69±7.48b 29.74±7.96c 0.001 
RNFLT: retinal nerve fiber layer thickness, GC: ganglion cell layer thickness, sup: superior, inf: inferior, CMT: 
central macular thickness, RPCP: radial peripapillary capillary plexus, FAZ: foveal avascular zone, VD: vessel 
density, SCP: Superficial capillary plexus, DCP: Deep capillary plexus. a: statistically significantly different 
when group 1 is compared with the control group; b: statistically significantly different when group 2 is 
compared with the control group; c: statistically significantly different when group 3 is compared with the control 
group. The significant P values expressed with bold style. 
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Table 3. Correlation analysis performed between the clinical features and OCT-A 
findings. 
 FAZ VD superficial VD deep 
 r p r p r p 
Age (years) 0.086 0.373 -0.190 0.045 -0.218 0.022 
BMI 0.275 0.004 -0.354 0.001 -0.349 0.001 
HbA1c 0.022 0.818 -0.190 0.046 -0.189 0.048 
HOMA-IR 0.022 0.817 -0.044 0.649 -0.027 0.783 
CRP 0.111 0.249 -0.129 0.180 -0.145 0.131 
AI 0.113 0.157 -0.254 0.007 -0.213 0.026 
BMI: Body mass index, HbA1c: hemoglobin A1C, CRP: C-reactive protein, AI: atherogenic index. The significant 
P values expressed with bold style. 
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Introduction: The classic presentation of pigmentary dispersion syndrome (PDS) often consists 
of midperipheral iris transillumination defects, Krukenberg’s spindle, and dense homogeneous 
trabecular pigmentation. Other subtle, sometimes overlooked features include pigment on the 
lens zonules, pigment on the anterior lens capsule and pigment along the equator of the pos-
terior lens capsule.
Case: This unique presentation of PDS presented with bilateral, dense, oblique, and symmetrical 
pigment deposition along the posterior lens capsule that changed in shape, density, and extent 
over the span of 3 years.
Discussion: There have been few reports in the literature that describe a central accumulation 
of pigment along the posterior lens capsule associated with PDS. There are reported cases of 
pigment deposition along the central aspect of the posterior lens capsule, some changing over 
time, although none were bilateral and symmetrical. There are suggestions that perhaps this cen-
tral pigment deposition is related to a break in the ligament of Weiger, allowing communication 
between the posterior chamber and posterior lens capsule. This is a case in which curvilinear, 
symmetrical, and changing pigment deposition on the posterior lens capsule is suggestive of 
perhaps another key features of PDS.
Keywords: pigment deposition, ligament of Weiger, space of Berger, zonules, pigmentary 
glaucoma
Introduction
Pigmentary dispersion syndrome (PDS) has many distinct clinical features that aide 
in its diagnosis and management. Ritch et al1 estimated the prevalence of PDS to be 
2.45% of Caucasian patients in a glaucoma screening. Roberts et al2 estimated the 
prevalence of PDS to be 0.0015% of African Americans in a primary care setting. 
These estimates are likely disparate because of the difference in phenotypic expression 
between the two ethnicities, as noted by Roberts et al.2 Although PDS is autosomal 
dominant in nature3 for both African American and Caucasian populations, it is thought 
to have incomplete penetrance in the African American population.4 Myopia has been 
noted as a significant corollary to PDS. Scheie and Cameron5 reported the incidence of 
myopia to be 65% in a group of 493 eyes with PDS, regardless of ethnicity. The clas-
sic clinical presentation of PDS includes midperipheral iris transillumination defects, 
Krukenberg’s spindle, and dense homogeneous trabecular pigmentation.6 Other clinical 
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features that are often overlooked may include pigment on 
the lens zonules7 and pigment on the anterior and posterior 
lens capsule.8 It is estimated that patients with PDS have 
a 35%–50% chance of developing pigmentary glaucoma 
during their lifetime.9 Below is a case in which the patient 
presented with many of the known features of PDS, along 
with an uncommon presentation of symmetrical pigment on 
both posterior lens capsules with changes in morphology 
and density over time.
Case
A 45-year-old Caucasian male initially presented with 
reduced acuities in both eyes since childhood. His medical 
and family history was unremarkable, with best-corrected 
acuities 20/60 in each eye and correction –8.00–2.00×135 
OD and –8.00–1.25×020 OS. External examination was 
normal, but slit lamp examination revealed midperipheral 
iris transillumination defects (Figure 1), pigment on the 
corneal endothelium and dense, and symmetrical pigment 
on the posterior lens capsules. Gonioscopy revealed angles 
open to ciliary body with grade 2+ pigment in all quadrants 
and no evidence of angle recession. Intraocular pressures 
(IOPs) were 17 and 18 mmHg in each eye. Dilated fundus 
examination with binocular indirect ophthalmoscopy and 
scleral depression revealed an intact retina, with no holes 
or tears and no signs of pigmented cells in the vitreous. 
The optic nerves were small: ~1 mm ×1 mm as measured 
with Spectral Domain Optical Coherence Tomography (SD-
OCT; © 2017; Carl Zeiss Meditec AG, Jena, Germany). We 
confirmed optic disc hypoplasia in both eyes as the likely 
cause of the patient’s decreased vision. Over the course of 
3 years, the IOP remained in the 15–19 mmHg range in both 
eyes. During this time, retinal nerve fiber layer thinning and 
corresponding visual field defects were evident. Given the 
presence of optic nerve hypoplasia in addition to PDS, it was 
difficult to assess the damage solely related to glaucomatous 
changes. For this reason, glaucoma therapy was initiated 
using Travatan Z ophthalmic solution once daily in both 
eyes. IOPs remained stable at 13 mmHg in each eye, and 
he continues to be monitored for any changes. Of particular 
interest was the unusual presentation of pigment deposition 
on the posterior lens capsules of each eye. The pattern of 
pigment was dense, oblique, and curvilinear and located 
along the posterior lens capsules (Figure 2). The pigment on 
the posterior capsule created shadows on the retina, which 
were best documented with Optos Daytona ultra-widefield 
imaging (© 2017; Optos plc, Dunfermline, UK), which pro-
vides ultra-widefield fundus imaging (Figure 3). Over time, 
it appeared that there was an increase in pigment deposition 
along the posterior lens capsule. Comparing photos 1 year 
apart, one can observe the apparent increase in the size of 
pigment deposition (Figure 4A and B). Interestingly, photos 
taken 2 years later showed a marked decrease in pigment 
deposition on the posterior lens capsules (Figure 5). There 
were no changes in the patient’s medical history in that same 
time span, including a repeated denial of medication changes 
or incidents of trauma. A search of literature published in the 
last 15 years did not reveal any cases of bilateral, dense, and 
symmetrical pigment deposition on the posterior lens capsule 
with a change in morphology over time.
Informed consent
The patient described in this case has given written informed 
consent to have the case details and accompanying images 
published.
Discussion
A ring-shaped deposition of pigment on the equator of the 
posterior lens capsule along the zonular attachments can be 
found in patients with PDS.7 Proximal to the zonules is the 
ligament of Weiger, which is the ring-like attachment of the 
anterior limiting membrane of the vitreous to the posterior 
lens capsule. Another ring of pigment, known as Scheie’s line, 
Figure 1 Midperipheral iris transillumination defects of the left eye, seen by direct 
illumination of the globe via transilluminator applied directly to lower lid in the dark.
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An atypical presentation of pigmentary dispersion syndrome
can deposit at the juncture of the ligament of Weiger.8 The 
ligament of Weiger encircles the space of Berger, which is 
located between the posterior lens capsule and the vitreous.10 
This space is located centrally through the visual axis and is 
typically void of debris assuming that the ligament of Weiger 
remains intact.11 In our patient, we observed an unusual and 
dramatic deposition of pigment on the central aspect of the 
posterior lens capsule, which was remarkably symmetrical 
when comparing one eye with the other. Theoretically, if the 
ligament of Weiger is intact, there should not be communica-
tion between the posterior chamber and the potential space 
of Berger.10 In our case, the pigment on the central aspect 
of the posterior lens capsule appeared to increase and then 
to decrease in size over time (Figures 4A and B vs Figure 
5). A possible explanation for this points to a break in the 
ligament of Weiger. If there was a break in the ligament of 
Weiger and the anterior hyaloid remained intact, it would 
allow aqueous to traverse from the posterior chamber to the 
space of Berger. The constant flow of aqueous through this 
space could bring loose iris pigment to deposit on the central 
aspect of the posterior lens capsule and then over time dis-
place this same pigment to a different location. Given there 
was no pigment visualized in the vitreous and there were no 
retinal breaks noted on fundus examination, we believe the 
pigment cells in our patient originated from the iris, rather 
than the retina. Roberts et al11suggested that a disruption in 
Figure 2 Circumlinear deposition of dense pigment along the posterior lens capsule of each eye.
Notes: The deposition in each eye (arrows) is virtually a mirror image of the other. The view with biomicroscopy of the posterior lens capsule matched the “shadow” seen 
with ultra-widefield images on each visit as seen in Figures 3–5.
Figure 3 Optos Daytona ultra-widefield imaging of each eye reveals shadows cast on the fundus from the pigment on the posterior lens capsule.
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this natural barrier, such as with trauma, may allow pigment 
to enter the potential space of Berger. However, a bilateral 
break in the ligament of Weiger is rare without trauma and, 
therefore, remains to be explained. It should be noted that 
the commencement of travoprost drops after the first 3 years 
of observation could have had an effect on the change in 
pigment. We do not feel that this change is significant, given 
that pigment deposition also decreased over time while on the 
same medication. Additionally, photos in Figure 4A and B 
were taken by the Optos Daytona and those in Figure 5 were 
taken by Optos California Daytona ultra-widefield imaging 
(© 2017; Optos plc). We do not believe that this would have 
Figure 4 (A) Optos Daytona ultra-widefield images highlight an increase in pigment over time of the right eye from 2013 (left) to 2014 (right). (B) Optos Daytona ultra-
widefield images highlight an increase in pigment over time of the left eye from 2013 (left) to 2014 (right). 
Note: These are visualized by the shadows cast on the retina (arrows) from the pigment deposition along the posterior lens capsule.
Figure 5 Optos California images from 2016 reveal a decrease in pigment over time of the right eye (left) and left eye (right) compared to 2013 and 2014 (Figure 4A and B).
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An atypical presentation of pigmentary dispersion syndrome
a significant impact on imaging the pigment on the posterior 
lens capsule.
There are few cases in the literature that describe find-
ings of bilateral and symmetrical pigment deposition on the 
posterior lens capsule with changes in morphology over time. 
Al-Mezaine12 reported a case of unilateral pigment deposition 
with a history of trauma in that same eye. Nagarajaiah and 
Shun-Shin,13 Lin et al,14 and Turgut et al15 describe cases of 
unilateral pigment deposition on the posterior lens capsule 
without a history of trauma. Nagarajaiah’s case is similar 
to ours in that the pigment was noted to change over time. 
Roberts et al11 reported a case of bilateral pigment deposition 
with the history of trauma in only one eye and a second case 
of unilateral pigment deposition without trauma. His first 
case is most similar to ours in that there was bilateral pigment 
deposition; however, his patient did not present with symmetry 
between the two eyes, nor was it noted to change over time.
As hypothesized earlier, a break in the ligament of Weiger 
is the only way in which pigment can reach the space of Berger. 
Since cases of spontaneous breaks in the ligament of Weiger 
are rare,16 we propose another mechanism for this break. Bernal 
et al17 were able to describe and document the precise inser-
tion of the anterior and posterior zonules to the lens capsule. 
Traditionally, it was thought that both the anterior and posterior 
zonules began at the ciliary body and inserted directly to the 
lens. Bernal confirmed that the anterior zonules have a straight 
path from the ciliary body to the lens. However, the majority 
of the posterior zonules first inserted into the anterior hyaloid 
membrane proximal to the ciliary body and then to the lens 
capsule. Some of these fibers inserted into areas close to Wei-
ger’s ligament before adhering to the posterior lens capsule.17 If 
one could imagine the posterior bowing of the iris in a patient 
with PDS and its relationship to the anterior zonules, it could 
be perceived that such rubbing against the anterior zonules 
could also affect the posterior zonules, especially those which 
are directly adherent to the ligament of Weiger. After years of 
chronic contact, this would promote detachment of the liga-
ment of Weiger, thereby allowing pigment to enter the space 
of Berger. Given that central posterior lens capsule pigmenta-
tion is not common in all patients with PDS, we propose that 
the amount of iris bowing may be related to this mechanical 
break in the ligament and perhaps a more concave iris would 
be more likely to cause a break in the ligament. The degree of 
iris concavity was not measured in our case but perhaps opens 
an area for future research.
The unusual presentation of the density, symmetry, and 
changing morphology of pigment has not been described 
previously in literature. This has clinical significance because 
if the known and sometimes subtle findings of PDS such 
as Krukenberg’s spindle, iris transillumination defects, and 
pigmented trabecular meshwork are initially overlooked by 
the examiner, observation of pigment on the posterior lens 
capsule may promote the examiner to check for these fea-
tures more closely. Additionally, future studies relating the 
degree of iris bowing to a break in the ligament of Weiger 
may confirm such a relationship and thereby identify a new 
subset of patients with this feature of PDS.
Disclosure
The authors report no conflicts of interest in this work.
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